Mexico's Federal Consumer Prosecutor's Office (Profeco), along with the Federal Commission for Protection against Health Risks (Cofepris), issued a warning on Wednesday about the illegal sale of products containing tirzepatida through e-commerce platforms, websites, and mobile applications. In a statement, the authorities noted that the alert concerns products from the brands Rapha, Dr. Pen, and Peptide Xperts, which are offered in presentations such as drops, patches, vials, and pre-filled syringes. Cofepris warned that these products “lack sanitary registration for their distribution in the national territory,” making their sale illegal. Tirzepatida is a weekly injectable medication primarily used to treat type 2 diabetes and for significant weight loss in adults with obesity or being overweight. The health authority explained that tirzepatida is a medication that must be used only under a medical prescription, in accordance with Article 226 of the General Health Law, and warned that its use without specialized supervision can cause health issues and even organ failure. Its indiscriminate use without the supervision of a specialist can cause stress or overactivity in organs such as the liver or pancreas, among others, which can lead to their failure. Due to the risk, Cofepris recommended not to acquire or use these products and to report their possible irregular sale to the health authority. Likewise, it asked those who are using them to immediately discontinue their consumption and see a health professional for a medical evaluation. In case of adverse reactions, people can report them through Cofepris's pharmacovigilance system or at farmacovigilancia@cofepris.gob.mx.
